Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

54.74
BATS BZX Real-Time Price
As of 9:27am ET
 -0.34 / -0.62%
Today’s Change
45.69
Today|||52-Week Range
61.70
+3.63%
Year-to-Date
The Zacks Analyst Blog Highlights: Zoetis, McKesson, Merck, Endo International and Am...
10:04am / Zacks.com
Gilead (GILD) Lags Q1 Earnings & Revenues, '16 View Intact
Apr 29 / Zacks.com
3 Dirt-Cheap Biotech Stocks To Buy
8:14am / MotleyFool.com
9 Figures That Sum Up Gilead Sciences' First Quarter
Apr 28 / MotleyFool.com
5 Data Points Wall Street Is Anxiously Awaiting in Merck's Q1 Report
May 03 / MotleyFool.com
AbbVie (ABBV) Beats on 1Q Earnings, Lowers View on Deal
Apr 28 / Zacks.com
Drug Stocks Reporting Mid-Week: MRK, ABC, ENDP & More
May 03 / Zacks.com
3 Healthcare Stocks Billionaires Love Right Now
Apr 28 / MotleyFool.com
Forget Bluebird Bio, Inc.: These 3 Stocks Are Better Buys
May 03 / MotleyFool.com
UnitedHealths Obamacare Changes to Affect Healthcare Sector
Apr 27 / GuruFocus News
Good News: Gilead Sciences Discounted Its Drugs Again
May 02 / MotleyFool.com
Today's Top Performers In Health Care
Apr 27 / TheStreet.com
Merck (MRK) Q1 Earnings: Can the Stock Pull a Surprise?
May 02 / Zacks.com
4 Biotech Stocks Reporting on Apr 28: AMGN, GILD, ALXN, CELG
Apr 27 / Zacks.com
Don't Give Up on Gilead Following a Weak Q1
May 02 / TheStreet.com
5 Stocks With Bigger Dividends Than Merck & Co.
Apr 25 / MotleyFool.com
Must-See Charts: How Healthy Are Bristol-Myers, Eli Lilly, Pfizer, Merck?
May 02 / TheStreet.com
Healthcare Q1 Earnings Look Solid: ETFs to Benefit
Apr 25 / Zacks.com
Slew Of Negative News, Defaults And Failed Mergers Push Futures In The Green
May 02 / Investing Channel
Vaccine development needs global alliance
Apr 24 / FT.com
What Does It Take to Outperform the S&P 500? We Asked a Board Member Who Does It
Apr 30 / TheStreet.com
Vaccines are among big pharma's best-selling products
Apr 24 / FT.com
Apple Drives Selloff on April's Last Trading Day
Apr 29 / TheStreet.com
3 Things to Watch in Gilead Sciences, Inc.'s First-Quarter Results
Apr 23 / MotleyFool.com
Stocks Sell Off in Final Trading Day of April
Apr 29 / TheStreet.com
Roche 'very optimistic' on prospects for new cancer drugs
Apr 19 / FT.com
Gilead Sciences, Inc. Reports Disappointing Q1 Harvoni Sales
Apr 29 / MotleyFool.com